Search Site

Jan Claassen, MD, PhD, FNCS

  • Associate Professor of Neurology at CUMC
  • Head of Neurocritical Care and Medical Director of the Neurological Intensive Care Unit
Jan Claassen, MD, PhD, FNCS

Dr. Claassen is a nationally and internationally recognized expert in the treatment of neurological intensive care. He is an expert in status epilepticus and brain hemorrhages. He is the co-chair for guidelines development for the Neurocritical Care Society.

Dr. Claassen received a PhD in neurophysiology studying evoked potentials after traumatic brain injury. He has published more than 150 journal articles, book chapters, and reviews.

He has championed the use of innovative brain monitoring techniques including continuous EEG monitoring.

He has published more than 150 journal articles, book chapters, and reviews. His research characterizes physiologic changes following acute brain injury, focusing on novel treatment approaches to potentially improve patient outcomes.

Departmental Appointments

  • Department of Neurology
    Division of Critical Care and Hospitalist Neurology

Languages Spoken

(in addition to English)

  • German

Education & Training

  • University of Hamburg, Germany
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Residency: Harlem Hospital Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

NIH Grants

  • AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SAGE-547 INJECTION AS ADJUNCTIVE THERAPY IN THE TREATMENT OF ADULTS WITH SUPER-REFRACTORY STATUS EPILEPTICUS (P&S Industry Clinical Trial)

    Jan 14 2014 - Jan 14 2019

    UTILITY OF INTRAVENOUS LACOSAMIDE COMPARED WITH FOSPHENYTOIN IN THE TREATMENT OF PATIENTS WITH FREQUENT NONCONVULSIVE SEIZURES (P&S Industry Clinical Trial)

    Oct 30 2013 - Oct 30 2018

    NEUROLOGICAL EMERGENCIES TREATMENT TRIALS (NETT)- ESETT (Federal Gov)

    Sep 30 2014 - Feb 28 2018

    COMBINING CLINICAL DATA AD TRANSDERMAL ANALYSIS OF WHOLE BLOOD TO CREATE A NEXT-GENERATION WEARABLE DEVICE (Federal Gov)

    Sep 15 2016 - Sep 14 2017

    FUTILITY STUDY OF DEFEROXAMINE MESYLATE IN INTRACEREBRAL HEMORRHAGE (I-DEF) (Federal Gov)

    Sep 1 2014 - Aug 31 2016

    A COLLABORATIVE STUDY OF RECOVERY OF CONSCIOUSNESS AFTER SEVERE BRAIN INJURY - PHASE II (Private)

    Aug 1 2013 - Jul 31 2016

    SAFETY EVALUATION OF 3K3AAPC IN ISCHEMIC STROKE-RHAPSODY-NEURONEXT (Federal Gov)

    Jul 1 2015 - Jun 30 2016

    NEUROLOGICAL EMERGENCIES TREATMENT TRIALS (NETT)- PROTECT (Federal Gov)

    Sep 1 2013 - Jun 30 2016

    CASUAL INFERENCE IN LARGE - SCALE TIME - SERIES WITH RARE EVENTS AND LATENT VARIABLES (Federal Gov)

    Jun 1 2013 - May 31 2016

    NEUROLOGICAL EMERGENCIES TREATMENT TRIALS (NETT) (Federal Gov)

    Sep 1 2013 - Jan 31 2016

    NEUROLOGICAL EMERGENCIES TREATMENT TRIALS (NETT)-RAMPART (Federal Gov)

    Sep 1 2013 - May 31 2015

    CRITICAL CARE EEG MONITORING RESEARCH CONSORTIUM (Private)

    Jan 1 2014 - Dec 31 2014

    NEUROLOGICAL EMERGENCIES TREATMENT TRIALS (NETT)-SHINE (Federal Gov)

    Sep 1 2013 - Jul 31 2014

    SEIZURE DETECTION IN CRITICALLY ILL PATIENTS (Private)

    Jun 5 2012 - Jun 4 2013